180 related articles for article (PubMed ID: 12705687)
21. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility and genetic relationships among Streptococcus dysgalactiae subsp. equisimilis isolates in Rio de Janeiro.
de Souza JP; Santos AR; de Paula GR; Barros RR
Infect Dis (Lond); 2016 Sep; 48(9):676-81. PubMed ID: 27301015
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
Lo HH; Nien HH; Cheng YY; Su FY
J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
[TBL] [Abstract][Full Text] [Related]
24. Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea.
Kim HY; Uh Y
Yonsei Med J; 2004 Aug; 45(4):591-7. PubMed ID: 15344198
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.
Yan JJ; Wu HM; Huang AH; Fu HM; Lee CT; Wu JJ
J Clin Microbiol; 2000 Jul; 38(7):2475-9. PubMed ID: 10878028
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
27. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
[TBL] [Abstract][Full Text] [Related]
29. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
30. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Perez-Trallero E; Urbieta M; Montes M; Ayestaran I; Marimon JM
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):25-31. PubMed ID: 9512178
[TBL] [Abstract][Full Text] [Related]
31. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.
Kataja J; Huovinen P; Skurnik M; Seppälä H
Antimicrob Agents Chemother; 1999 Jan; 43(1):48-52. PubMed ID: 9869564
[TBL] [Abstract][Full Text] [Related]
32. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
[TBL] [Abstract][Full Text] [Related]
33. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.
York MK; Gibbs L; Perdreau-Remington F; Brooks GF
J Clin Microbiol; 1999 Jun; 37(6):1727-31. PubMed ID: 10325315
[TBL] [Abstract][Full Text] [Related]
34. [Characteristics and related factors related to the resistance on antibiotics among group A streptococcus strains isolated from children in Beijing, during May and July 2011].
Liu S; Li J; Peng XM; Yang P; Zhang DT; Wu SS; Cui SJ; Liu YM; Wang QY
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Nov; 33(11):1133-8. PubMed ID: 23290898
[TBL] [Abstract][Full Text] [Related]
35. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece.
Petinaki E; Kontos F; Pratti A; Skulakis C; Maniatis AN
Int J Antimicrob Agents; 2003 Jan; 21(1):67-70. PubMed ID: 12507840
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of resistance for Streptococcus pyogenes in northern Utah.
Rowe RA; Stephenson RM; East DL; Wright S
Clin Lab Sci; 2009; 22(1):39-44. PubMed ID: 19354028
[TBL] [Abstract][Full Text] [Related]
37. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
38. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.
De Azavedo JC; Yeung RH; Bast DJ; Duncan CL; Borgia SB; Low DE
Antimicrob Agents Chemother; 1999 Sep; 43(9):2144-7. PubMed ID: 10471555
[TBL] [Abstract][Full Text] [Related]
40. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.
Portillo A; Lantero M; Gastañares MJ; Ruiz-Larrea F; Torres C
Int J Antimicrob Agents; 1999 Oct; 13(2):137-40. PubMed ID: 10595574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
